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Neurodevelopmental disorders (NDDs) caused by aberrant brain growth and development are 
life-long, debilitating illnesses that markedly impair the quality of life. Animal models are a 
valuable tool for studying NDD pathobiology and therapies. Mounting evidence suggests the 
zebrafish (Danio rerio) as a useful model organism to study NDDs with high physiological 
homology to humans and sensitivity to pharmacological and genetic manipulations. Here, we 
summarize experimental models of NDDs in zebrafish and highlight the growing translational 
significance of zebrafish NDD-related phenotypes. We also emphasize the need in further 
development of zebrafish models of NDDs to improve our understanding of their pathogenesis 
and therapeutic treatments. 
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Neurodevelopmental disorders (NDDs) are life-long debilitating conditions caused by 
aberrant growth and development of the central nervous system (CNS) (Thapar A et al., 
2017;Young S et al., 2018). Currently recognized major clinical NDDs, to be discussed here, 
include communication disorders, autism spectrum disorder (ASD), attention 
deficit/hyperactivity disorder (ADHD), intellectual disability (ID), specific learning disorder and 
motor/tic disorders (American Psychiatric A, 2013). For example, ASD causes robust behavioral 
(e.g., hyperactivity, repetitive behaviors), emotional (e.g., low affectivity/empathy) and social 
deficits (American Psychiatric A, 2013;Elsabbagh M et al., 2012;Lainhart JEJIRoP, 
1999;Simonoff E et al., 2013). ADHD causes hyperactivity and inattention (e.g., easy distraction 
and impulsivity) (American Psychiatric A, 2013;Mayes SD et al., 2000;Mayes SD and Calhoun 
SLJCN, 2007). Global developmental delay (Moeschler JB and Shevell M, 2014) is characterized 
by delay in motor, speech/language, cognitive, social/personal, and activities of daily living 
(Shevell MI et al., 2003). Another common NDD, ID presents as reduced intellectual functioning 
and adaptive behavior, impaired conceptual, social and practical adaptive skills (Schalock RL et 
al., 2007), as well as deficits in cognitive capacities (American Psychiatric A, 2013). 
The etiology of NDDs is multi-factorial, complex and poorly understood (Gathercole SE 
et al., 2006;Krakowiak P et al., 2012;Lewis DA and Levitt PJAron, 2002;Newcorn JH et al., 
2015;Thapar A,Cooper M and Rutter MJTLP, 2017). For instance, ADHD is associated with 
complications at birth, as well as genetic and environmental factors (e.g., chemical exposure or 
drug intake during gestation) (Lou HJAP, 1996;Millichap JGJP, 2008;Nigg JTJJoCC and 
Psychology A, 2012;Thapar A et al., 2013). ASD is linked to metabolic pathologies during 
pregnancy (e.g., obesity, diabetes) and immune disorders (Currenti SAJC and neurobiology m, 
2010;Krakowiak P,Walker CK,Bremer AA,Baker AS,Ozonoff S,Hansen RL and Hertz-Picciotto 
IJP, 2012;Pessah IN et al., 2008). Genetic factors also play a role in NDDs, for example, causing 
specific NDD (e.g., Down, Smith-Magenis and William’s-Beuren) syndromes (Martens G and 
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van Loo KJCg, 2007). However, the underlying mechanisms of NDDs remain unclear (Martens 
G and van Loo KJCg, 2007;Miles JHJGiM, 2011), necessitating further research in this field.  
Animal models have been used to evaluate the etiology and develop new therapies for 
NDDs and associated comorbidities (Gatto CL and Broadie KJCoin, 2011;Kalueff AV et al., 
2014;Meyer U et al., 2009;Tropepe V et al., 2003). Complementing rodent models, the zebrafish 
(Danio rerio) is emerging as a valuable model organism in CNS research and drug screening 
(Best J et al., 2008;Khan KM et al., 2017;MacRae CA and Peterson RTJNrDd, 2015;Rihel J and 
Schier AFJDn, 2012). Here, we summarize the mounting evidence for modeling NDDs in 
zebrafish, focusing on important translational lessons from using this model organism and 
selected NDDs chosen based on the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V (American Psychiatric A, 2013)). 
A small teleost fish, the zebrafish has a short reproductive cycle and transparent embryos 
and larvae, enabling an easy assessment of their neurodevelopment (Kimmel CB et al., 
1995;Singleman C and Holtzman NGJZ, 2014). Zebrafish have four developmental stages: 
embryo (until the protruding mouth, ~72 hours past fertilization, hpf); larva (3-30 days past 
fertilization, dpf); juvenile fish (attaining a complete pattern of scales and completely losing the 
larval fin fold; 1-3 months), and adult fish (defined by the production of viable gametes and 
ability to breed) (Kimmel CB,Ballard WW,Kimmel SR,Ullmann B and Schilling TFJDd, 1995). 
The structural and anatomical formation of zebrafish CNS initiates early (Kimmel 
CB,Ballard WW,Kimmel SR,Ullmann B and Schilling TFJDd, 1995;Papan C and Campos-
Ortega JAJRsaodb, 1994), with neuronal formation beginning at 16 hpf (Kimmel CB et al., 
1991). By 17 hpf, zebrafish brain forms its sub-regions, including the midbrain-hindbrain 
boundary, cerebellum and thalamus (Gutzman JH et al., 2008;Hanneman E et al., 1988;Kimmel 
CB,Ballard WW,Kimmel SR,Ullmann B and Schilling TFJDd, 1995;Kimmel CBJAron, 1993). 
The blood-brain barrier begins to form at 20 hpf, demonstrating the well-developed microglia 
and complete barrier structure at 3 dpf (Herbomel P et al., 1999;Quiñonez-Silvero C et al., 2019). 
The neural signaling systems, which are ontogenetically homologous to mammalian systems, 
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form between 18-32 hpf and include the catecholaminergic (Holzschuh J et al., 2001;Mueller T 
and Wullimann M, 2015), gamma-aminobutyric acid (GABA)-ergic and glutamatergic systems 
(Higashijima SI et al., 2004).  
Zebrafish model of selected neurodevelopmental disorders 
Zebrafish are actively used to model various aspects of ASD, including sociocognitive 
deficits and behavioral perseverations (Meshalkina DA et al., 2018;Stewart AM et al., 2014). For 
example, mimicking ASD-like phenotypes, dizocilpine (MK-801), a non-competitive glutamate 
N-methyl-D-aspartate (NMDA) receptor antagonist, evokes social deficits (impaired shoaling) 
in adult fish (Seibt KJ et al., 2011;Zimmermann FF et al., 2016). Zebrafish mimic pathological 
effects of ASD following larval valproate exposure during neurodevelopment (Dwivedi S et al., 
2018), causing overt deficits in social interaction as adults (Zimmermann FF et al., 2017). 
Valproate exposure during early life also alters brain development, promotes cell proliferation 
and neurogenesis (including in regions that may contribute to brain overgrowth and 
macrocephaly), and causes behavioral (e.g., hyperactivity and ASD-like social deficits) and 
genomic (i.e., gene expression-based; e.g., upregulated adsl (adenylosuccinate lyase) and mbd5 
(methyl-CpG binding domain protein 5), downregulated shank3a (SH3 and multiple ankyrin 
repeat domains 3a) and tsc1b (tuberous sclerosis complex 1)) responses in embryonic and larval 
zebrafish (Chen J et al., 2018;Lee S et al., 2018).  
Environmental factors that may promote AD clinically include pesticides, solvents and 
air pollutants (Rossignol DA et al., 2014;Ye BS et al., 2017). Suggesting some predictive 
validity, zebrafish NDD-related phenotypes can also be corrected by clinically active drugs. For 
example, risperidone, an atypical antipsychotic used to reduce anxiety and aggression in ASD 
children (McCracken JT et al., 2002), lowers anxiety-like behavior and cortisol levels caused by 
acute stress (net chasing) in zebrafish (Idalencio R et al., 2015). Aripiprazole, another atypical 
antipsychotic used to control irritability, hyperactivity and stereotypies in ASD (Accordino RE 
et al., 2016), similarly reduces stress response in zebrafish (Barcellos HHD et al., 2016). 
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Animal models are important tools for studying the genetic complexity of NDDs 
(Banerjee S et al., 2014;Hoffman EJ, 2014). For example, the contactin associated protein-like 2 
(CNTNAP2) gene is up-regulated in ASD patients (Arking DE et al., 2008;Strauss KA et al., 
2006). In line with this, zebrafish CNTNAP2 mutants display nocturnal hyperactive behavior and 
GABAergic deficits, which can be reversed by treatment with estrogens (e.g., estradiol cypionate 
and Biochanin A) (Hoffman EJ et al., 2016). A homozygous founder mutation in TRAPPC6B is 
also associates with human ASD (Marin-Valencia I et al., 2018), and zebrafish trappc6b 
morphants parallel some human NDD phenotype, displaying microcephaly and neuronal hyper-
excitability (Marin-Valencia I,Novarino G,Johansen A,Rosti B,Issa MY,Musaev D,Bhat G,Scott 
E,Silhavy JL and Stanley V, 2018). Zebrafish knockouts of synaptic ras gtpase activating protein 
1 (SYNGAP1) and the SH3 and multiple ankyrin repeat domains 3 (SHANK3) genes recapitulates 
developmental delay in ASD (Kozol RA et al., 2015), including delayed mid/hindbrain 
development, motor deficits (unproductive swim attempts) and spontaneous seizure-like 
behaviors (Kozol RA,Cukier HN,Zou B,Mayo V,De Rubeis S,Cai G,Griswold AJ,Whitehead 
PL,Haines JL and Gilbert JRJHmg, 2015). The shank3b mutant fish display morphological and 
behavioral deficits (e.g., reduced locomotion an social interaction) (Liu C-x et al., 2018). 
Dyrk1aa knockout zebrafish exhibit social impairments that reproduce human phenotypes of 
ASD, as well as lower c-fos in hypothalamus vs. wild type, suggesting that the knockout fish 
brain is less activated by social contexts (Kim O-H et al., 2017). Morpholino shank3b knockdown 
zebrafish exhibit reduced social interaction, spend less time near conspecifics, and repetitive 
swimming behaviors in both larvae and adults (Liu C-x et al., 2018).  
Common phenotypes associated with ADHD include inattention, impulsiveness and 
hyperactivity (Winstanley CA et al., 2006), which all can be evaluated in zebrafish (Fontana BD 
et al., 2019). Both adult and larvae zebrafish can also be useful to model pathological 
hyperactivity and impulsivity, common in ADHD (Blaser R et al., 2010;Ellis LD et al., 
2012;Fontana BD,Franscescon F,Rosemberg DB,Norton WHJ,Kalueff AV and Parker MO, 
2019;Saili KS et al., 2012). For example, exposure to 1% alcohol evokes zebrafish motor 
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hyperactivity following dopaminergic stimulation (Nowicki M et al., 2015). Likewise, models 
have been developed to assess the ability of adult zebrafish to respond to impulsiveness and 
attention stimulus (Parker MO et al., 2014;Parker MO et al., 2013), as well as to evaluate 
neurochemical (e.g., monoaminergic) mechanisms of impulsivity in these fish (Parker MO,Brock 
AJ,Sudwarts A and Brennan CH, 2014).  
Genetic risks of ADHD include the gene variants in the latrophilin 3 (LPHN3) gene 
(Martinez AF et al., 2016), whose lphn3.1 ortholog down-regulation in zebrafish evokes 
hyperactivity and impulsivity, similarly to ADHD patients (Lange M et al., 2012). The nocturnal 
hyperactivity behaviors in ADHD are associated with clock genes polymorphisms (Kissling C et 
al., 2008;Mogavero F et al., 2018). As neuromedin U (Nmu) promotes hyperactivity and inhibits 
sleep in larvae, the nmu mutant animals present hypoactive phenotype (Chiu CN et al., 2016). In 
addition, zebrafish knockouts of the clock gene period1b (per1b) exhibit similar hyperactivity, 
impulsivity and circadian disturbances to clinical ADHD (Huang J et al., 2015). The zebrafish 
Depdc5 knockdown and period1b mutants can also be used as ADHD model in zebrafish, 
showing both hyperactivity and cognitive deficits (de Calbiac H et al., 2018;Wang T et al., 2018) 
(note, however, that hyperactivity is a rather non-specific behavioral alteration, and its presence 
alone may not be sufficient to mimic ADHD). Zebrafish can also help evaluate new treatments 
for AHDH. For example, auriculasin, a prenylated isoflavones from Flemingia philippinensis, 
reduces hyperactivity and increases melatonin and dopamine in period1b-/- zebrafish (Wang 
T,Liu Y,Liu H,Li C and Wang Y, 2018). Likewise, zebrafish contactin associated protein-like 2 
(cntnap2) mutants display ADHD-like hyperactivity and GABAergic deficits in the forebrain, 
which can be reversed by phytoestrogen biochanin A (Hoffman EJ et al., 2016). 
Relevant to modeling ID, ethanol exposure during neurodevelopment induces learning 
and memory deficits in zebrafish (Carvan III MJ et al., 2004;Fernandes Y et al., 2014;Luchiari 
AC et al., 2015), strikingly resembling human fetal alcohol syndrome (FAS). The bromodomain 
PHD finger transcription factor (BPTF) variants are found in patients with global developmental 
delay/ID, speech delay, postnatal microcephaly, and dysmorphic features (Stankiewicz P et al., 
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2017). Zebrafish knockout of bptf causes smaller head size and abnormal craniofacial patterning 
(Stankiewicz P,Khan TN,Szafranski P,Slattery L,Streff H,Vetrini F,Bernstein JA,Brown 
CW,Rosenfeld JA and Rednam S, 2017). The X-linked genetic syndrome associated with 
mutations in TAF1 gene presents global developmental delay and ID. Zebrafish morpholino of 
taf1 ortholog reduces the optic tectum, demonstrating that mutations in TAF1 play a critical role 
in the development of this X-linked ID (O’Rawe JA et al., 2015). In addition, mutations in 
exosome component 3 (EXOSC3) are associated with global developmental delay, cerebellar 
atrophy, progressive microcephaly and pontocerebellar hypoplasia type 1 (Wan J et al., 2012). 
Morpholino knockdown of exosc3 in zebrafish embryos causes embryonic microcephaly and 
poor motility, resembling some of clinical features (Wan J,Yourshaw M,Mamsa H,Rudnik-
Schöneborn S,Menezes MP,Hong JE,Leong DW,Senderek J,Salman MS and Chitayat D, 2012). 
Patients with dysfunction of Cyclin K (CCNK) display developmental delay, ID and language 
defects (Fan Y et al., 2018). Functional assay in zebrafish larvae show that Ccnk knockdown 
impairs brain and spinal cord development (Fan Y,Yin W,Hu B,Kline AD,Zhang VW,Liang 
D,Sun Y,Wang L,Tang S and Powis Z, 2018). Another candidate gene for reading problems and 
mild ID is CTNND2, and both humans and zebrafish with haploinsufficiency of this gene present 
cognitive dysfunction (Hofmeister W et al., 2015).   
As several motor disorders are also classified as NDDs, zebrafish emerge as a useful tool 
to unravel possible aberrant control of the motor system (Schilling TFJZ, 2002). For example, 
larvae exposure to ketamine evokes anxiety-like behavior and lower swimming speed (Félix LM 
et al., 2017) – the effects diminished by acetyl l-carnitine, which promotes neuroprotective 
effects and reduces the degeneration of Rohon-Beard sensory neurons in zebrafish (Cuevas E et 
al., 2013). The Rett syndrome is an X-linked neurodevelopmental disorder with mental 
retardation and a rapid regression of motor and cognitive skills. Mutations in the transcription 
factor MECP2 gene are present in >90% of Rett syndrome patients (Amir RE et al., 1999), and 
the Mecp2 knockout zebrafish display reduced swimming activity (Pietri T et al., 2013) and 
aberrant CNS brain-derived neurotrophic factor (bdnf) gene expression (Nozawa K et al., 2017). 
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 Microcephaly is a general comorbidity of many NDDs (Watemberg N et al., 2002;Woods 
CGJCoin, 2004), and zebrafish may help examine genetic implications and the molecular 
mechanisms of this disorder (Kim H-T et al., 2011;Novorol C et al., 2013). The autosomal 
recessive primary microcephaly (MCPH) is characterized by smaller cortices, which can be 
evaluated by expression of the abnormal spindle-like microcephaly associated gene (aspm) in 
zebrafish (Kim H-T,Lee M-S,Choi J-H,Jung J-Y,Ahn D-G,Yeo S-Y,Choi D-K,Kim C-HJB and 
communications br, 2011). Similarly, Fancd2 (fanconi anemia complementation group D2) 
mutants zebrafish also present microcephaly and microphthalmia, paralleling clinical phenotypes 
(Liu TX et al., 2003). The loss-of-function and missense variants in KIAA1109 are associated to 
autosomal-recessive multi-system Alkuraya-Kucinskas syndrome, and knockdown of the 
orthologous gene in zebrafish causes embryonic hydrocephaly (Gueneau L et al., 2018). Kabuki 
syndrome is a rare multiple congenital anomaly syndrome characterized by global developmental 
delay and ID due to mutations in the KMT2D and KDM6A genes. Zebrafish knockdown of kmt2d 
and the two zebrafish paralogues kdm6a and kdm6al present developmental abnormalities similar 
to Kabuki syndrome, as kdm6a and kmt2d morphants exhibit severe abnormalities in brain 
development (Van Laarhoven PM et al., 2015).  
Finally, schizophrenia is a critical, severely debilitating disorder, which is relevant to 
NDDs, affects approximately 1% globally and causes cognitive, emotional, social and perceptual 
dysfunctions (Association AP, 2013). Schizophrenia-like phenotypes can be studied in zebrafish 
using various tests to assess fish locomotor activity (Daggett J, 2016;Kysil EV et al., 2017;Wang 
L et al., 2016), as well as social (Wang L,Jiang W,Lin Q,Zhang Y and Zhao C, 2016), cognitive 
(Daggett J, 2016;Meshalkina DA et al., 2017) and aggressive behaviors (de Abreu MS et al., 
2019;Zabegalov KN et al., 2019), all commonly observed in schizophrenic patients. 
Schizophrenia-like states can also be induced experimentally, for example, mimicking the 
hypofunction of glutamatergic N-methyl-D-aspartate (NMDA) signaling (Farber NB, 2003). In 
zebrafish, a pro-psychotic drug dizocilpine (MK- 801) potently modulates a wide range of 
behavioral phenotypes, including those directly relevant to psychoses, such as motor 
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hyperactivity and social deficits, which are also reversed by clinically active antipsychotics 
sulpiride and olanzapine (Seibt KJ et al., 2010;Seibt KJ et al., 2011). In addition, several brain 
genes are associated with schizophrenia and can be evaluated in zebrafish, including the 
disrupted in schizophrenia 1 (disc1) and neuregulin 1 (nrg1) genes (Owen MJ et al., 2009), as 
well as glutamatergic and GABA-ergic genes, such as dysbindin (DTNBP1), catechol-O-
methyltransferase (COMT), proline dehydrogenase (PRODH), Metabotropic glutamate 
receptor-3 (GRM3; mGluR3), regulator of G-protein signaling 4 (RGS4) (Harrison PJ and 
Weinberger DRJMp, 2005;O’Tuathaigh CMP et al., 2007). 
General discussion 
Evidence summarized here suggests that zebrafish emerge as an important new model to 
study NDDs. Possessing several practical advantages, such as chorion transparency that allows 
easy observation of development, low cost and rapid development (Beliaeva N et al., 
2010;Tavares B and Lopes SSJAmp, 2013) (Fig. 1), zebrafish also present conserved 
GABAergic (Hortopan GA et al., 2010;Roy B and Ali DWJN, 2014), monoaminergic (Irons T 
et al., 2013;Souza BR and Tropepe VJRitn, 2011;Yamamoto K et al., 2010), purinergic (Piato 
AL et al., 2011;Zimmermann FF,Gaspary KV,Siebel AM,Leite CE,Kist LW,Bogo MR and 
Bonan CDJMn, 2017), glutamatergic (Rico EP et al., 2010;Vitale W, 2012) and melatonergic 
(Genario R et al., 2019) systems, as well as well-defined neuronal complexes (Jin Y et al., 
2018;Kabashi E et al., 2011;Panula P et al., 2006). In addition, zebrafish is an important model 
to assess chemical, neurotoxic and genetic insults during neural development (Giordani S and 
d'Amora MJFiN, 2018;Wang S et al., 2018). Zebrafish are further suitable for studying NDDs 
(Dorsemans A-C et al., 2017) due to high neuroplasticity, enabling the analyses of multiple 
neuronal adaptations (Ghosh S and Hui SP, 2016) and their behavioral (e.g., sociality or 
emotionality) correlates (Teles MC et al., 2016) controlled by relatively well-defined circuits 
(Perathoner S et al., 2016). The growing number of zebrafish genes whose orthologs have been 
implicated in human NDDs (Fontana BD,Franscescon F,Rosemberg DB,Norton WHJ,Kalueff 
AV and Parker MO, 2019;Meshalkina DA et al., 2018;Vaz R et al., 2019) supports the value of 
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this organism for developing new CNS targets. Finally, important advantages of zebrafish 
models of NDDs (over mammals) include their high-throughput potential (Jordi J et al., 2018) 
and better compliance, as lower vertebrates, with bioethical animal experimentation and 3R 
principles (de Abreu MS et al., 2019).  
However, as other in vivo models, zebrafish present certain limitations in regard to 
modeling NDDs. For example, zebrafish show overt differences in physiology compared to 
mammals, such as the external fertilization that does not mimic uterine development in mammals 
(d’Amora M and Giordani S, 2018). Another problem is that zebrafish present rather limited 
range of behavioral phenomena (e.g., it is unclear if depression-like states exist in zebrafish (de 
Abreu MS et al., 2018)) compared to other, much better  studied (e.g., rodent) NDDs models. 
Moreover, unlike mammals, zebrafish does not exhibit some critical brain areas (most notably, 
cerebral cortex (Kalueff AV et al., 2014)). It is also impossible to mimic some NDDs in zebrafish 
(e.g., speech sound disorder, stuttering, developmental coordination disorder, tic disorders, 
communication/language disorder), or to evaluate the role of neurodevelopment during gestation 
(due to external fertilization in fish). While zebrafish do present a complex behavioral repertoire 
(Ariyomo TO et al., 2013;Blaser R,Chadwick L and McGinnis GJBbr, 2010;Dreosti E et al., 
2015;Kalueff AV et al., 2013), the face validity of zebrafish models for NDDs remains unclear, 
and it is unlikely that all NDD symptoms can be recapitulated. In addition, unlike mammals, 
some zebrafish genes are duplicated as a result of teleost-specific genome duplication event 
(Howe K et al., 2013), with an average of 20–24% of genes duplicated (Howe K, Clark MD, 
Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews 
L, McLaren S, Sealy I, Caccamo M, Churcher C, Scott C, Barrett JC, Koch R, Rauch GJ, White 
S, Chow W, Kilian B, Quintais LT, Guerra-Assunção JA, Zhou Y, Gu Y, Yen J, Vogel JH, Eyre 
T, Redmond S, Banerjee R, Chi J, Fu B, Langley E, Maguire SF, Laird GK, Lloyd D, Kenyon 
E, Donaldson S, Sehra H, Almeida-King J, Loveland J, Trevanion S, Jones M, Quail M, Willey 
D, Hunt A, Burton J, Sims S, McLay K, Plumb B, Davis J, Clee C, Oliver K, Clark R, Riddle C, 
Elliot D, Eliott D, Threadgold G, Harden G, Ware D, Begum S, Mortimore B, Mortimer B, Kerry 
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G, Heath P, Phillimore B, Tracey A, Corby N, Dunn M, Johnson C, Wood J, Clark S, Pelan S, 
Griffiths G, Smith M, Glithero R, Howden P, Barker N, Lloyd C, Stevens C, Harley J, Holt K, 
Panagiotidis G, Lovell J, Beasley H, Henderson C, Gordon D, Auger K, Wright D, Collins J, 
Raisen C, Dyer L, Leung K, Robertson L, Ambridge K, Leongamornlert D, McGuire S, 
Gilderthorp R, Griffiths C, Manthravadi D, Nichol S, Barker G, Whitehead S, Kay M, Brown J, 
Murnane C, Gray E, Humphries M, Sycamore N, Barker D, Saunders D, Wallis J, Babbage A, 
Hammond S, Mashreghi-Mohammadi M, Barr L, Martin S, Wray P, Ellington A, Matthews N, 
Ellwood M, Woodmansey R, Clark G, Cooper J, Tromans A, Grafham D, Skuce C, Pandian R, 
Andrews R, Harrison E, Kimberley A, Garnett J, Fosker N, Hall R, Garner P, Kelly D, Bird C, 
Palmer S, Gehring I, Berger A, Dooley CM, Ersan-Ürün Z, Eser C, Geiger H, Geisler M, Karotki 
L, Kirn A, Konantz J, Konantz M, Oberländer M, Rudolph-Geiger S, Teucke M, Lanz C, Raddatz 
G, Osoegawa K, Zhu B, Rapp A, Widaa S, Langford C, Yang F, Schuster SC, Carter NP, Harrow 
J, Ning Z, Herrero J, Searle SM, Enright A, Geisler R, Plasterk RH, Lee C, Westerfield M, de 
Jong PJ, Zon LI, Postlethwait JH, Nüsslein-Volhard C, Hubbard TJ, Roest Crollius H, Rogers J 
and Stemple DL, 2013). This can result in redundant functions of various key brain genes related 
to NDDs, and may provide phenotypic buffering and/or complicating the generation of gene-
targeted (knockout or knockdown) diseases models (Kozol RA et al., 2016;Sakai C et al., 2018). 
Notably, the long-term effect of many zebrafish mutants is not characterized for adult 
zebrafish behavior, calling into question its predictive validity. Thus, studies aiming to 
characterize in detail the face and predictive validity of zebrafish NDDs models are still 
necessary if we are to understand the mechanisms of these disorders across the lifespan.  
Nevertheless, mounting evidence suggests that zebrafish models can be used to screen 
novel treatments for various NDDs. For example, screening of behavioral effects of over 10000 
drugs in larval zebrafish (Jordi J,Guggiana-Nilo D,Bolton AD,Prabha S,Ballotti K,Herrera 
K,Rennekamp AJ,Peterson RT,Lutz TA and Engert F, 2018) suggests several compounds which 
may help develop new ADHD therapies and improve our understanding of mechanisms and 
neural circuits involved in this disorder. Still, a large translational gap exists for animal models 
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of NDDs, including zebrafish models relevant to these conditions. In general, the translatability 
of findings obtained in animal models is generally associated with the range of mechanisms and 
phenotypic profiles that the animal model can address (Zeiss CJ and Johnson LK, 2017). The 
factors that may contribute to the reproducibility-translatability gap include relationships 
between the model choice (e.g., intended goal of the intervention) and the integration of 
biomarker data with outcome measures that are clinically relevant to humans (Zeiss CJJIj, 2017). 
Despite clear advantages as a model organism (discussed above), our present understanding of 
zebrafish NDD-related phenotypes and their molecular mechanisms remained limited, as is the 
number of established behavioral models and tests relevant to mimicking these disorders. 
Nevertheless, as animal models continue to play a key role in the identification of genetic and 
molecular targets to develop safer and more effective treatments for NDD, the zebrafish is 
emerging as a potentially promising species to generate important insights into pharmacological 
and genetic roles of NDDs. With many questions yet remaining open in this field (Table 1), this 
calls for further research utilizing zebrafish models of NDDs. 
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Figure 1. Schematic diagram emphasizing the advantages of using zebrafish to study 





Table 1. Selected open translational questions related to modeling neurodevelopmental 





• How to obtain zebrafish models that are most robust to study NDDs? 
• How can stress affect or trigger NDD pathogenesis in zebrafish? 
• What is the best genetic model for each NDDs in zebrafish? 
• Are there differences in genetic determinants of NDDs in humans vs. zebrafish? 
• What is the role of epigenetic modulations in NDDs? 
• Can gene-environment interactions and genetic predisposition factors in clinical NDDs be modeled in 
zebrafish? 
• What is the impact of sex differences in NDD models in zebrafish? 
• How to develop zebrafish models of NDDs that display sex differences in pathogenesis similar to those 
in humans? 
• How does zebrafish ‘personality’ contribute to the expression of NDD behaviors in various aquatic tests? 
• Can computer technologies (e.g., behavioral software) lead to automatic recognition and extraction of 
zebrafish NDD-related behaviors? 
• Do gut microbiota factors contribute to zebrafish NDD pathogenesis? 
• Do various zebrafish ‘NDDs’ respond similarly to clinically effective drugs as human NDDs?  
• How can current genetic tools (e.g., CRISPR) assist in the understanding of NDDs mechanisms? 
• Are there individual and strain differences of NDDs phenotypes in zebrafish? Are they stable/consistent 
between strains for all major NDD subtypes? 
• How to best differentiate phenotypes of each NDD in zebrafish (e.g., disrupted social behavior (ADHD 
vs. ASD)? 
• Which behavioral endpoints are shared/common in tasks assessing NDDs behaviors in zebrafish vs. 
other models? 
• Can zebrafish NDD models also mimic their frequent comorbidity with non-NDD (e.g., affective) 
disorders?  
• Are there species differences (e.g., Danio albolineatus vs. Danio rerio) in responsivity to drugs used in 
NDD treatment? 
Treatment-related 
• What is the impact of environmental enrichment therapy on zebrafish NDD models? 
• Can environmental factors modulate (e.g., decrease or potentiate) drug effects on zebrafish NDD-related 
phenotypes? 
• Can physiological treatments (e.g., diet interventions, exercise) so widely used to treat NDDs clinically 
exert similar therapeutic effects in zebrafish NDD models? 
• What are prospects of stem cell-based therapy of NDDs? 
• What is the clinical replicability of the NDD-related pharmacological effects in zebrafish? 
• What nootropic drugs are effective for NDDs treatment? 
• Can extensive regenerative capacity of zebrafish brain become a basis for novel NDD therapies? 
• How can neuroimmune mechanisms modulate zebrafish NDD-related phenotypes? 
• What are novel, principally new targets for NDD therapy? Can these novel drug targets be identified 
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